Metformin, a common diabetes medication, shows promise for the treatment of anxiety and depression. Read More
MDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms. Read More
Esketamine combined with antidepressants acts rapidly to help alleviate symptoms in those with treatment-resistant depression. Read More
Ketamine, an anesthetics which has been commonly used as an illicit party drug, is helping people overcome depression. The drug works rapidly and provides lasting relief from depressive symptoms for weeks after exposure. Researchers are examining how ketamine works in the brain to help positively influence behavior in those with mood disorders. Read More
Cannabidiol may buffer the effects of THC on the brain for those who use marijuana. Marijuana with a higher CBD content restores disruptions to the salience network caused by THC exposure. Read More
A newly developed drug can help combat the effects of postnatal depression. Read More
NV-5138, a small molecule drug that mimics the action of ketamine, provides fast-acting antidepressant responses in rodent models of depression. The drug is currently undergoing Phase 1 testing in humans. Read More
MDMA, a psychedelic drug, has successfully been used to reopen the 'critical period' of learning the reward values of social behaviors. Researchers report, in mature mice given MDMA, oxytocin triggers signaling in synapses that help encode social learning and memory, a process that does not usually occur in older animals. The findings could help in the development of treatments for PTSD and other disorders. Read More
Psychostimulant use in young adults is correlated with an increased risk of stroke. Read More
The mGlu2 receptor plays a critical role in the effectiveness of ketamine for treating depression. Read More
A new study reports those who microdose psychedelics report improvements in attention and mental health. However, a number of people report an increase in neuroticism following six weeks of microdosing. Read More
A new study reveals the combination of ketamine with naltrexone can help treat symptoms of both depression and addiction. Read More
